AstraZeneca Pharma India discontinues manufacturing of Imdur

AstraZeneca Pharma India Limited will be discontinuing with the manufacturing and marketing of the product prolonged release Isosorbide-5-mononitrate Tablets BP 30 mg and 60 mg (Imdur) from April 1, 2025. Imdur is currently being indicated for Prophylactic treatment of angina pectoris.

Morepen Laboratories approves term loan facility from Shinhan Bank

The Finance Committee of the Board of Directors of Morepen Laboratories Limited has approved, term loan facility from Shinhan Bank to the extent of Rs. 25 crore and entered into a 'Loan Agreement' with the Bank.

Pharmaids enters into loan agreement

Pharmaids Pharmaceuticals Limited has entered into a Loan Agreement dated 28-03-2025 for availing loan amount of up to Rs 10 crore in one or more tranches from Dr. Shankarappa Nagaraja Vinaya Babu, Chairman and Non-Executive and Non Independent Director of the Company, for the purpose of working capital requirements, general business purpose and Repayment of loan & liabilities of the Company.

Dr. Agarwal's Health Care opens new branch in Eluru

Dr. Agarwal's Health Care Limited has commenced operations of a new branch in Eluru, Andhra Pradesh with effect from March 27, 2025.